| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Brivanib |
|---|
| Description | Brivanib is a potent, ATP-competitive inhibitor against human Flk-1 (VEGFR-2) and mouse Flk-1 with IC50 of 25 nM and 89 nM, respectively. Brivanib also inhibits VEGFR-1 and FGFR-1 with IC50 values of 0.38 and 0.148 μM. Brivanib displays antitumor activities in H3396 xenograft. MW: 370.38. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (R)-1-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)oxy)propan-2-ol; BMS-540215 |
|---|
| Gene, Accession, CAS # | CAS: 649735-46-6 |
|---|
| Catalog # | B1325-5 |
|---|
| Price | |
|---|
| Order / More Info | Brivanib from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|